ArticleMolecular cancer therapeutics2017

JAK1/STAT3 Activation through a Proinflammatory Cytokine Pathway Leads to Resistance to Molecularly Targeted Therapy in Non-Small Cell Lung Cancer.

Kazuhiko Shien et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.